Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

2020 New Drug Update.

Daniel A Hussar, Laura A Finn

The Senior Care Pharmacist

|March 21, 2020

Summary

This summary is machine-generated.

This review evaluates five new drugs from 2019 for common conditions in older adults, including Parkinson's disease and osteoporosis. Each drug is rated based on its benefits and drawbacks to guide clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Student Pharmacist State Anxiety on Vasopressor Calculation Accuracy in Advanced Cardiac Life Support Simulations.

American journal of pharmaceutical education·2024

Same author

A Tribute to Dr. Daniel A. Hussar.

The Senior care pharmacist·2021

Same author

New Drugs 2021, Part 2.

Nursing·2021

Same author

New Drugs 2021, Part 1.

Nursing·2021

Same author

New Drug Update 2020.

The Senior care pharmacist·2021

Same author

New drugs 2020, part 3.

Nursing·2020

Same journal

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026

Same journal

Transitioning Medication-Related Home Visits to a Cognitively Accessible Digital Intervention in Home Care: A Practice Innovation Pilot.

The Senior care pharmacist·2026

Same journal

Perception of Technology to Support Medication Management Among Community-dwelling African American Older Adults.

The Senior care pharmacist·2026

Same journal

ASCP Policy Review Committee.

The Senior care pharmacist·2026

Same journal

Initial Evaluation of L-mMRC Severity Tool in Staging COPD in the Skilled Nursing Setting.

The Senior care pharmacist·2026

Same journal

Dispense This: How AI Is Reshaping Pharmacy's Clinical Services.

The Senior care pharmacist·2026

See all related articles

Area of Science:

Geriatric Medicine
Pharmacology
Drug Development

Background:

Older adults often face multiple chronic conditions.
New pharmaceutical agents are continually developed to address unmet medical needs in this demographic.
The year 2019 saw the market release of several novel medications targeting prevalent diseases in the elderly population.

Purpose of the Study:

To review and assess five new drugs marketed in the US in 2019 for conditions common in older individuals.
To provide a comparative analysis of these new pharmaceutical agents.
To rate the new drugs using the author's developed New Drug Comparison Rating system (DAH).

Main Methods:

Literature review of five new drugs approved in 2019.
Analysis of drug uses, properties, advantages, and disadvantages.

Related Experiment Videos

Application of the New Drug Comparison Rating system (DAH) for drug evaluation.

Main Results:

Detailed discussion of uses and key properties for each new drug.
Identification of specific benefits and limitations for each agent.
A comparative rating assigned to each new drug based on the DAH system.

Conclusions:

The review provides a structured assessment of new medications for older patients.
The DAH rating system offers a framework for comparing new drugs based on clinical utility.
Informed decision-making for prescribing new drugs in geriatric populations is facilitated.